Melnick R L
Division of Biometry and Risk Assessment, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709.
Regul Toxicol Pharmacol. 1992 Oct;16(2):111-25. doi: 10.1016/0273-2300(92)90052-b.
Based on associations between the accumulation of protein droplets containing alpha 2u-globulin in proximal tubular epithelial cells and increased incidences of renal tubular neoplasms in male rats, it has been suggested that the carcinogenicity of chemicals that cause alpha 2u-globulin nephropathy is unique to animals that synthesize this protein. Chemicals that caused alpha 2u-globulin nephropathy and renal carcinogenicity in male rats have not been shown to produce renal tumors in animals that lack the capability for hepatic alpha 2u-globulin synthesis, including female rats, male NBR rats, or mice of either sex. Because humans do not synthesize alpha 2u-globulin it has been suggested that chemicals which cause renal toxicity associated with alpha 2u-globulin accumulation do not pose an increased cancer risk to humans. In this review on the association between alpha 2u-globulin nephropathy and renal carcinogenesis, it is apparent that (a) there are data inconsistent with the hypothesis linking these occurrences, (b) alternative mechanisms of renal toxicity and carcinogenicity are plausible, (c) data on quantitative dose-response correspondences between the various stages of alpha 2u-globulin nephropathy and renal carcinogenicity are limited, and (d) a greater understanding of the molecular changes occurring during renal carcinogenesis is needed before assuming that the current hypothesis is correct. Future research aimed at resolving issues raised in this paper should help determine whether or not the association between alpha 2u-globulin nephropathy and renal carcinogenesis represents a cause-and-effect relationship.
基于雄性大鼠近端肾小管上皮细胞中含有α2u-球蛋白的蛋白质滴积累与肾小管肿瘤发病率增加之间的关联,有人提出,导致α2u-球蛋白肾病的化学物质的致癌性对于合成这种蛋白质的动物来说是独特的。在缺乏肝脏α2u-球蛋白合成能力的动物(包括雌性大鼠、雄性NBR大鼠或任何性别的小鼠)中,尚未发现能在雄性大鼠中引起α2u-球蛋白肾病和肾致癌性的化学物质会产生肾肿瘤。由于人类不合成α2u-球蛋白,因此有人提出,导致与α2u-球蛋白积累相关的肾毒性的化学物质不会增加人类患癌症的风险。在这篇关于α2u-球蛋白肾病与肾致癌作用之间关联的综述中,很明显:(a)存在与将这些事件联系起来的假设不一致的数据;(b)肾毒性和致癌性的替代机制是合理的;(c)关于α2u-球蛋白肾病各个阶段与肾致癌性之间定量剂量反应对应关系的数据有限;(d)在假设当前假设正确之前,需要更深入地了解肾致癌过程中发生的分子变化。旨在解决本文提出问题的未来研究应有助于确定α2u-球蛋白肾病与肾致癌作用之间的关联是否代表因果关系。